Answers are grounded in this paper and cite their sources.
The paper “Report on Mortality from Gluteal Fat Grafting: Recommendations from the ASERF Task Force” is a timely and sobering submission that has many wide-reaching implications for patients and plastic surgeons alike.1 As the authors describe, fat grafting of the buttocks is a popular procedure in the United States and worldwide, with an impressive growth rate over the last several years. As demand for this procedure has risen, so too has the number of surgeons offering this procedure. Despite scattered reports of patient deaths over the years from “buttock injections,” buttock augmentation with autologous fat grafting has been considered by both the public and most plastic surgeons who perform the procedure to be safe, with an acceptable risk profile for major complications. This perception has been mostly drawn from and validated by most published series’ on the topic, with two recent exhaustive reviews of the literature published just in 2016 (one by discussant S.W. Jr) demonstrating mostly favorable risk profiles for the procedure.2,3 Bolstered by these and other published studies on buttock fat grafting, the plastic surgical community continued to proceed under the assumption that any patient deaths were the result of nonplastic surgeons performing back room or home-based procedures using bathroom caulk and industrial grade silicone gel,4 or if performed by plastic surgeons, that deaths are due to largely uncontrollable factors after surgery, such as venous thrombo-embolus (VTE). The authors of this report, through a variety of sources, have made it clear both of these assumptions were ill founded and that the alarm bell is now ringing loudly. The sentinel alarm bell came from Cárdenas-Camarena’s, “Deaths Caused by Gluteal Lipoinjection: What Are We Doing Wrong?,”5 disclosing not only the alarming mortality rate of this procedure in Mexico and Columbia by legitimate plastic surgeons, but also that mortality from this procedure is caused by an intraoperative complication, pulmonary fat embolus (PFE). Despite Cárdenas-Camarena’s revelations and increasing concern among surgeons regarding the safety of gluteal fat grafting, it was not until Mofid et al’s report, which was based on a survey of American Society for Aesthetic Plastic Surgery (ASAPS) and International Society of Aesthetic Plastic Surgery (ISAPS) members, as well as additional sources of data, that two crucial elements were provided in order for the scope of the problem to be fully realized. The first is that many of these deaths from gluteal fat grafting are the result of surgeries by board-certified plastic surgeons and members of the ASAPS, both synonymous with the highest quality plastic surgery in the United States. The second is that this report is the first to estimate a mortality rate for gluteal fat grafting, while also providing incidence rate ratios for different technical aspects of the surgery. Despite the complexities of coalescing multiple sources of data, the authors also provide recommendations on gluteal fat grafting while making it clear that more research and understanding is necessary to improve the safety of this procedure. The authors are to be congratulated on all of these as well as additional aspects of the report. The authors are to be congratulated for their diligence in retrieving and analyzing data from multiple disparate sources, including their survey of ASAPS and ISAPS members, anecdotal reports from surgeons, coroner reports, medical examiner reports, surgeon interviews, ASAPS procedural statistics, and data from AAAASF and CosmetAssure. The sheer number of data sources required for this submission creates an element of complexity that most manuscripts do not have to contend with, and the authors should be commended for their efforts in providing meaningful data and conclusions. The many limitations are well outlined by the authors and are mainly due to the fact that they are drawn mostly from the authors’ retrospective survey of anonymous surgeons, also utilizing and citing supporting data from many of the above-mentioned sources. We agree with the authors that further research is needed in order to adequately and fully determine the scope of the problem, or problems, with the way this procedure is being typically performed. Adding to the difficulty of this determination is that most surgeons have their “own way” to perform the procedure and that there is no widely accepted or “standard” way to perform autologous fat grafting to the gluteal region. As reviewers and also as daily practitioners of this procedure for many years, we can offer several thoughts regarding this report as well as the state of safety of buttock fat grafting and its prospects for improvement, with the caveat that some issues and limitations of the report should be further discussed, with most of the limitations being from the survey. The 15-question survey that was administered, analyzed, and ultimately published by the authors was difficult to formulate, with different thoughts among task force members as to the best ways to ask questions that would give the most useful information.6 Although some statistically significant data did result from many of the questions, allowing for recommendations to be made, other questions did not appear to yield enough information to make useful recommendations. Optimal volumes injected, size of syringes, syringe vs inline systems, various access points, and patient positioning questions are such examples where the authors did not provide recommendations. This is not a criticism of the survey, but rather, an observation that may speak to the difficulty in quickly or easily recommending a technical “standard” for this procedure by leveraging information from existing techniques and technologies. That said, both commenters believe a technical standard in gluteal fat grafting with an acceptable risk profile will be achieved within 3 to 5 years due to ongoing innovation, studies, and research in fat science and fat transplantation, some of which is being performed by the commenters. A disappointing aspect of this report is that the retrospective anonymous surgeon survey had a response rate of 14%. Although we presume to know the incidence of pulmonary fat embolism and mortality for these respondents, what we definitely do not know is what the incidence of PFE and mortality is in the 86% of plastic surgeons who received this survey and elected not to fill it out. There are many reasons why individuals do not fill out surveys and many other reasons why they do. In addition to recall bias, which the authors discuss, other biases in surveys are well known, such as participation bias and subject bias. Participation bias is a phenomenon in which the results of elections, studies, polls, etc., become nonrepresentative because the participants disproportionately possess certain traits which affect the outcome. In this context, one might imagine surgeons who had experienced a PFE in their past responding to the survey, having a greater interest in the topic, a higher degree of remorse, guilt, and feeling of catharsis by filling out the survey. Conversely, a surgeon without a PFE may elect not to fill out the survey based on the lack of the above traits. Subject bias, also known as participant bias, is a tendency of participants (subjects) in an experiment to consciously or subconsciously act in a way that they think the experimenter/researcher wants them to act. It often occurs when subjects realize or know the purpose or goals of the study. As stated in the Results, at least 2 respondents were omitted from the study because of “unusually high outlier responses” attributed to “most likely due to an erroneous entry while completing the survey.” In one such case, the surgeon reported 9 deaths.6 This may represent subject bias. By falsely increasing the incidence of this complication, the respondent might feel like he or she is in “good company.” Of course, there are other explanations for these outlier responses, with the caveat being that their omission does cast more doubt on the validity of the incidence rates from the survey. Although no one can deny that a death is a death, and the 25 confirmed fatal PFEs in the United States over a 5.75 year period that were found by the task force are indisputable, the true incidence of fatal fat embolism from large-volume fat grafting to the buttock in the study may be different than stated due to participation and/or subject bias, in addition to arguably arbitrary disregard of certain respondents’ data, as described above. As the authors state, recall bias could also play a role, although a surgeon forgetting about a death or near death in a patient from PFE seems unlikely, regardless of when in the past it occurred. Looking closer at the survey data, it was not surprising to see that the incidence of fatal and nonfatal PFE was statistically higher when injecting in deep vs superficial planes, although it was interesting to note that when comparing the 2 options that comprise the superficial planes, those being the subcutaneous plane and the superficial to mid muscle planes, the lowest risk of PFE resulted from the superficial to midmuscle injections, demonstrating a 19% greater risk reduction compared to subcutaneous injection. The authors do not offer any theories as to this seemingly contradictory finding of a deeper injection plane being “safer” than the most superficial plane, but we would agree with the authors that there can be many reasons why the reporting of which plane a surgeon used could be incorrect or false, especially in a case that resulted in a PFE. Incorrect or false reporting could result from survey respondents who thought they were superficial but they were actually not, or they stated they were superficial but they knew they were not. We emphasize this point regarding more superficial planes of injection, and are in agreement with the authors that PFE does not substantially occur without some introduction of fat into the venous system, with the highest concentration of large, accessible veins being in the deeper planes. Given this, we think it is imperative to avoid injury to the substantial venous structures which are located in the deep intramuscular and submuscular planes. An understanding of buttock and pelvic anatomy is essential in knowing where these deep venous structures reside. An interesting comparison can be made to fat grafting of the breast. Consider that many thousands of fat grafting to the breast procedures have been performed,7 all of which include fat grafting into the subcutaneous plane. Included in these numbers are over 6000 such operations by just three of the busiest breast fat grafting surgeons in the world,8-10 yet it appears that there have been no published reported cases of fatal or nonfatal PFE from fat transplantation to the breast, despite the breast subcutaneous anatomy being rich in venous and arterial structures, as is the gluteal subcutaneous tissue. A possibly crucial difference in this comparison is that the analogous large-caliber veins in the breast are protected by an overlying and difficult to penetrate ribcage. In contrast, the gluteal anatomy has no such protective barrier. The authors also further our understanding of PFE by offering several theories and figures in regard to its etiology, several of which we have also described and articulated elsewhere.11 Many of these theories have shaped how we approach this operation from a technical and instrumentation standpoint, illustrating how we view small-volume and large-volume fat transplantation as very different procedures that require sometimes drastic differences in how they are performed. For instance, we use stiff, large-diameter, exploded-tipped cannulae with an inline, powered system devoid of syringes for gluteal fat grafting. Such a large, rigid system may seem strange to those accustomed to small-volume fat grafting using a small-gauge needle connected to a syringe, until one considers that the authors derived by statistical analysis that larger cannulae appear to have a lower incidence of PFE in gluteal fat grafting. We are in complete agreement with the authors’ recommendation to use cannulae larger than 4.1 mm. It is likely that the authors found that the survey data corroborated their findings from interviews of experienced surgeons who have no PFE complications and that these surgeons tended toward using larger cannulae. These findings and recommendation to use larger cannulae may seem counter-intuitive to surgeons experienced in the practice of small-volume fat grafting, but as we are learning more with time and experience, large-volume fat transplantation and small-volume fat transplantation are very different entities that are best practiced each according to their own set of rules. The use of larger diameter cannulae with rigid, inline, large-bore connections is not just about improving fat flow and reducing shear. It is also very much about increased stiffness and better control of the entire apparatus, allowing for precise tactile feedback and knowledge of the tip of the cannula at all times. When considering “traditional” syringe techniques, we defined flexibility misguidance as a phenomenon involving a thin gauge injection cannula attached to a syringe, whereby penetration and advancement of the cannula in the tissues creates a bending of the cannula and syringe interface that can lead to deeper and deeper tissue planes despite the “straight” guidance of the cannula, which acts as a curved cannula in this scenario. Flexibility misguidance is quite possibly the number one reason why fatal pulmonary fat embolus occurs, when a surgeon’s tactile feedback tells him or her the cannula is superficial but it is not. All it takes is for one errant stroke to injure the venous system and lacerate a vein, and fat embolism can occur. The exact mechanism of how fat gains entry to the lacerated vein is debatable, but avoiding laceration in the first place is not. Therefore, the knowledge of the location of the cannula tip seems to be the sine qua non of PFE avoidance in fat transplantation of the buttock. We congratulate the authors on this important contribution and for bringing this grim reality to light. Fat grafting to the buttock, as it is most commonly performed today, carries disproportionate risks of mortality, the reasons for which are still not well understood or delineated, and requires further research and study. We would propose that the road to improved safety for this popular operation will be in finding better techniques, improved systems of instrumentation, and a comprehensive understanding of fat science and buttock anatomy. The authors are the founders of Surgistem Technologies, LLC (Dover, DE), which develops, manufactures, and commercializes instrumentation for large-volume fat transplantation. The authors received no financial support for the research, authorship, and publication of this article.
No takes yet. Share an insight, caveat, or question.
Wall et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: